Cargando…

Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients

Retinal vascular occlusion is the most common cause of retinopathy leading to severe visual loss in all age groups. Central retinal vein occlusion (CRVO) is usually seen in older age group and is often associated with systemic vascular diseases. Although the exact cause and effect relationship has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Rohina S, Mishra, Vineet V, Aggarwal, Somesh V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713585/
https://www.ncbi.nlm.nih.gov/pubmed/23869159
http://dx.doi.org/10.4103/0974-1208.112389
_version_ 1782277210966589440
author Aggarwal, Rohina S
Mishra, Vineet V
Aggarwal, Somesh V
author_facet Aggarwal, Rohina S
Mishra, Vineet V
Aggarwal, Somesh V
author_sort Aggarwal, Rohina S
collection PubMed
description Retinal vascular occlusion is the most common cause of retinopathy leading to severe visual loss in all age groups. Central retinal vein occlusion (CRVO) is usually seen in older age group and is often associated with systemic vascular diseases. Although the exact cause and effect relationship has not been proven, central retinal vein occlusion has been associated with various systemic pathological conditions, hence a direct review of systems toward the various systemic and local factors predisposing the central retinal vein occlusion is advocated. We describe the development of central retinal venous occlusion with associated cystoid macular edema (CME) in two healthy infertile women who were recruited for in vitro fertilization cycle for infertility. Predisposing risk factors associated with central retinal vein occlusion are obesity, sedentary life style, smoking, and some systemic diseases such as hyperlipidemia, hypertension, associated autoimmune disorders e.g., antiphospholipid antibody syndrome, lupus, diabetes mellitus, cardiovascular disorders, bleeding or clotting disorders, vasculitis, closed-head trauma, alcohol consumption, primary open-angle glaucoma or angle-closure glaucoma. In our patients, they were ruled out afterdoing allpertaining investigations. The cases were managed with further avoidance of oral contraceptives and intra-vitreal injections of Bevacizumab (Avastin), an anti-vascular endothelial growth factor (anti-VEGF drug) and Triamcinolone acetonide (a long acting synthetic steroid). Hence, even if no systemic diseases are detected. Physical examinations are recommended periodically for young women on oral contraceptive pills.
format Online
Article
Text
id pubmed-3713585
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37135852013-07-18 Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients Aggarwal, Rohina S Mishra, Vineet V Aggarwal, Somesh V J Hum Reprod Sci Case Report Retinal vascular occlusion is the most common cause of retinopathy leading to severe visual loss in all age groups. Central retinal vein occlusion (CRVO) is usually seen in older age group and is often associated with systemic vascular diseases. Although the exact cause and effect relationship has not been proven, central retinal vein occlusion has been associated with various systemic pathological conditions, hence a direct review of systems toward the various systemic and local factors predisposing the central retinal vein occlusion is advocated. We describe the development of central retinal venous occlusion with associated cystoid macular edema (CME) in two healthy infertile women who were recruited for in vitro fertilization cycle for infertility. Predisposing risk factors associated with central retinal vein occlusion are obesity, sedentary life style, smoking, and some systemic diseases such as hyperlipidemia, hypertension, associated autoimmune disorders e.g., antiphospholipid antibody syndrome, lupus, diabetes mellitus, cardiovascular disorders, bleeding or clotting disorders, vasculitis, closed-head trauma, alcohol consumption, primary open-angle glaucoma or angle-closure glaucoma. In our patients, they were ruled out afterdoing allpertaining investigations. The cases were managed with further avoidance of oral contraceptives and intra-vitreal injections of Bevacizumab (Avastin), an anti-vascular endothelial growth factor (anti-VEGF drug) and Triamcinolone acetonide (a long acting synthetic steroid). Hence, even if no systemic diseases are detected. Physical examinations are recommended periodically for young women on oral contraceptive pills. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3713585/ /pubmed/23869159 http://dx.doi.org/10.4103/0974-1208.112389 Text en Copyright: © Journal of Human Reproductive Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Aggarwal, Rohina S
Mishra, Vineet V
Aggarwal, Somesh V
Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title_full Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title_fullStr Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title_full_unstemmed Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title_short Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients
title_sort oral contraceptive pills: a risk factor for retinal vascular occlusion in in-vitro fertilization patients
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713585/
https://www.ncbi.nlm.nih.gov/pubmed/23869159
http://dx.doi.org/10.4103/0974-1208.112389
work_keys_str_mv AT aggarwalrohinas oralcontraceptivepillsariskfactorforretinalvascularocclusionininvitrofertilizationpatients
AT mishravineetv oralcontraceptivepillsariskfactorforretinalvascularocclusionininvitrofertilizationpatients
AT aggarwalsomeshv oralcontraceptivepillsariskfactorforretinalvascularocclusionininvitrofertilizationpatients